Industry
Local drug firms largely managed by young owners
Feb. 27, 2017
Young owner members of major South Korean pharmaceutical manufacturers, such as sons and grandsons of company founders, are on the fast track to management positions, industry sources said Monday. Lim Jong-hoon, third son of Hanmi Pharmaceutical Chairman Lim Sung-ki, is set to be registered as a member of the board of directors during the shareholder meeting scheduled for March 10, the sources said.(Yonhap)Lim Jong-hoon, 40, who has so far served as the company's director, will join the manageme